Skip to main content
Top
Published in: Reviews in Endocrine and Metabolic Disorders 2/2021

01-06-2021 | Simvastatin

A network analysis framework of genetic and nongenetic risks for type 2 diabetes

Authors: Yuan Zhang, Shu Li, Zhi Cao, Yangyang Cheng, Chenjie Xu, Hongxi Yang, Li Sun, Hongxiao Jiao, Ju Wang, Wei-Dong Li, Yaogang Wang

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 2/2021

Login to get access

Abstract

Both genetic and nongenetic factors have been found to be associated with type 2 diabetes, however, the correlation between them is still unclear. In the present study, we aimed to fully decipher the nongenetic and genetic factor association network for type 2 diabetes. We identified risk factors for type 2 diabetes by systematically searching for related meta-analyses and genome-wide association studies (GWAS) database. Among a total of 27,822 studies screened, 202 articles were eligible, from which 174 nongenetic factors and 210 genetic factors associated with type 2 diabetes were identified. Then, we obtained 584 associations between the nongenetic and genetic factors of type 2 diabetes, based on which a risk factor association network was conducted. The nongenetic factors could be classified into seven categories according to the Global Burden of Diseases (GBD). Of these seven categories of nongenetic factors, five were found to be correlated with genes associated with type 2 diabetes, including environmental risks, behavioral risks, metabolic risks, related disease of type 2 diabetes, and treatments. Specifically, air pollutants of environmental risks, alcohol using of behavioral risks, obesity of metabolic risks, rheumatoid arthritis of related disease risk, and simvastatin of treatment was correlated with the largest number of genes. In summary, the correlation between genetic factors and nongenetic factors identified in this study indicates that there is a common phenotype-genotype association in type 2 diabetes, with the combinations of genotypes (“genetic signature”) clustering in phenotypes related to type 2 diabetes. Thus, we should take a systematic approach to explore the relationship of various factors for type 2 diabetes, as well as other noncommunicable diseases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Yu D, Zheng W, Cai H, Xiang YB, Li H, Gao YT, et al. Long-term diet quality and risk of type 2 diabetes among urban Chinese adults. Diabetes Care. 2018;41(4):723–30.PubMedCrossRef Yu D, Zheng W, Cai H, Xiang YB, Li H, Gao YT, et al. Long-term diet quality and risk of type 2 diabetes among urban Chinese adults. Diabetes Care. 2018;41(4):723–30.PubMedCrossRef
2.
go back to reference Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6(1):69–80.PubMedCrossRef Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6(1):69–80.PubMedCrossRef
3.
go back to reference Eltom MA, Babiker Mohamed AH, Elrayah-Eliadarous H, Yassin K, Noor SK, Elmadhoun WM, et al. Increasing prevalence of type 2 diabetes mellitus and impact of ethnicity in North Sudan. Diabetes Res Clin Pract. 2018;136:93–9.PubMedCrossRef Eltom MA, Babiker Mohamed AH, Elrayah-Eliadarous H, Yassin K, Noor SK, Elmadhoun WM, et al. Increasing prevalence of type 2 diabetes mellitus and impact of ethnicity in North Sudan. Diabetes Res Clin Pract. 2018;136:93–9.PubMedCrossRef
4.
go back to reference Bullard KM, Cowie CC, Lessem SE, Saydah SH, Menke A, Geiss LS, et al. Prevalence of diagnosed diabetes in adults by diabetes type - United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(12):359–61.PubMedPubMedCentralCrossRef Bullard KM, Cowie CC, Lessem SE, Saydah SH, Menke A, Geiss LS, et al. Prevalence of diagnosed diabetes in adults by diabetes type - United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(12):359–61.PubMedPubMedCentralCrossRef
5.
go back to reference Zhang P, Gregg E. Global economic burden of diabetes and its implications. Lancet Diabetes Endocrinol. 2017;5(6):404–5.PubMedCrossRef Zhang P, Gregg E. Global economic burden of diabetes and its implications. Lancet Diabetes Endocrinol. 2017;5(6):404–5.PubMedCrossRef
6.
go back to reference Martinez-Ceron E, Garcia-Rio F. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;377(3):300.PubMedCrossRef Martinez-Ceron E, Garcia-Rio F. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;377(3):300.PubMedCrossRef
7.
go back to reference Norhammar A. Diabetes and cardiovascular mortality: the impact of sex. Lancet Diabetes Endocrinol. 2018;6(7):517–9.PubMedCrossRef Norhammar A. Diabetes and cardiovascular mortality: the impact of sex. Lancet Diabetes Endocrinol. 2018;6(7):517–9.PubMedCrossRef
8.
go back to reference Newman JD, Schwartzbard AZ, Weintraub HS, Goldberg IJ, Berger JS. Primary prevention of cardiovascular disease in diabetes mellitus. J Am Coll Cardiol. 2017;70(7):883–93.PubMedPubMedCentralCrossRef Newman JD, Schwartzbard AZ, Weintraub HS, Goldberg IJ, Berger JS. Primary prevention of cardiovascular disease in diabetes mellitus. J Am Coll Cardiol. 2017;70(7):883–93.PubMedPubMedCentralCrossRef
9.
go back to reference Bommer C, Heesemann E, Sagalova V, Manne-Goehler J, Atun R, Barnighausen T, et al. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol. 2017;5(6):423–30.PubMedCrossRef Bommer C, Heesemann E, Sagalova V, Manne-Goehler J, Atun R, Barnighausen T, et al. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol. 2017;5(6):423–30.PubMedCrossRef
10.
go back to reference Hasnain SZ, Borg DJ, Harcourt BE, Tong H, Sheng YH, Ng CP, et al. Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress. Nat Med. 2014;20(12):1417–26.PubMedCrossRef Hasnain SZ, Borg DJ, Harcourt BE, Tong H, Sheng YH, Ng CP, et al. Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress. Nat Med. 2014;20(12):1417–26.PubMedCrossRef
11.
go back to reference Spiegel AM, Nabel EG. NIH research on obesity and type 2 diabetes: providing the scientific evidence base for actions to improve health. Nat Med. 2006;12(1):67–9.PubMedCrossRef Spiegel AM, Nabel EG. NIH research on obesity and type 2 diabetes: providing the scientific evidence base for actions to improve health. Nat Med. 2006;12(1):67–9.PubMedCrossRef
12.
go back to reference Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, Steinthorsdottir V, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981–90.PubMedPubMedCentralCrossRef Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, Steinthorsdottir V, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44(9):981–90.PubMedPubMedCentralCrossRef
13.
go back to reference Micha R, Penalvo JL, Cudhea F, Imamura F, Rehm CD, Mozaffarian D. Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. JAMA. 2017;317(9):912–24.PubMedPubMedCentralCrossRef Micha R, Penalvo JL, Cudhea F, Imamura F, Rehm CD, Mozaffarian D. Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. JAMA. 2017;317(9):912–24.PubMedPubMedCentralCrossRef
14.
go back to reference Lotta LA, Sharp SJ, Burgess S, Perry JRB, Stewart ID, Willems SM, et al. Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis. JAMA. 2016;316(13):1383–91.PubMedPubMedCentralCrossRef Lotta LA, Sharp SJ, Burgess S, Perry JRB, Stewart ID, Willems SM, et al. Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis. JAMA. 2016;316(13):1383–91.PubMedPubMedCentralCrossRef
15.
go back to reference Aikens RC, Zhao W, Saleheen D, Reilly MP, Epstein SE, Tikkanen E, et al. Systolic blood pressure and risk of type 2 diabetes: a Mendelian randomization study. Diabetes. 2017;66(2):543–50.PubMedCrossRef Aikens RC, Zhao W, Saleheen D, Reilly MP, Epstein SE, Tikkanen E, et al. Systolic blood pressure and risk of type 2 diabetes: a Mendelian randomization study. Diabetes. 2017;66(2):543–50.PubMedCrossRef
16.
go back to reference Knott C, Bell S, Britton A. Alcohol consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of more than 1.9 million individuals from 38 observational studies. Diabetes Care. 2015;38(9):1804–12.PubMedCrossRef Knott C, Bell S, Britton A. Alcohol consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of more than 1.9 million individuals from 38 observational studies. Diabetes Care. 2015;38(9):1804–12.PubMedCrossRef
17.
go back to reference He D, Wu S, Zhao H, Qiu H, Fu Y, Li X, et al. Association between particulate matter 2.5 and diabetes mellitus: a meta-analysis of cohort studies. J Diabetes Investig. 2017;8(5):687–96.PubMedPubMedCentralCrossRef He D, Wu S, Zhao H, Qiu H, Fu Y, Li X, et al. Association between particulate matter 2.5 and diabetes mellitus: a meta-analysis of cohort studies. J Diabetes Investig. 2017;8(5):687–96.PubMedPubMedCentralCrossRef
18.
go back to reference Flannick J, Florez JC. Type 2 diabetes: genetic data sharing to advance complex disease research. Nat Rev Genet. 2016;17(9):535–49.PubMedCrossRef Flannick J, Florez JC. Type 2 diabetes: genetic data sharing to advance complex disease research. Nat Rev Genet. 2016;17(9):535–49.PubMedCrossRef
19.
go back to reference Su S, Zhang C, Zhang F, Li H, Yang X, Tang X. The association between leptin receptor gene polymorphisms and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2016;121:49–58.PubMedCrossRef Su S, Zhang C, Zhang F, Li H, Yang X, Tang X. The association between leptin receptor gene polymorphisms and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2016;121:49–58.PubMedCrossRef
20.
go back to reference Kunutsor SK, Khan H, Laukkanen JA. Serum albumin concentration and incident type 2 diabetes risk: new findings from a population-based cohort study. Diabetologia. 2015;58(5):961–7.PubMedCrossRef Kunutsor SK, Khan H, Laukkanen JA. Serum albumin concentration and incident type 2 diabetes risk: new findings from a population-based cohort study. Diabetologia. 2015;58(5):961–7.PubMedCrossRef
21.
go back to reference Peng S, Zhu Y, Lu B, Xu F, Li X, Lai M. TCF7L2 gene polymorphisms and type 2 diabetes risk: a comprehensive and updated meta-analysis involving 121,174 subjects. Mutagenesis. 2013;28(1):25–37.PubMedCrossRef Peng S, Zhu Y, Lu B, Xu F, Li X, Lai M. TCF7L2 gene polymorphisms and type 2 diabetes risk: a comprehensive and updated meta-analysis involving 121,174 subjects. Mutagenesis. 2013;28(1):25–37.PubMedCrossRef
22.
go back to reference Yeh HC, Duncan BB, Schmidt MI, Wang NY, Brancati FL. Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med. 2010;152(1):10–7.PubMedPubMedCentralCrossRef Yeh HC, Duncan BB, Schmidt MI, Wang NY, Brancati FL. Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med. 2010;152(1):10–7.PubMedPubMedCentralCrossRef
23.
go back to reference Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2013;36(5):1422–8.PubMedPubMedCentralCrossRef Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2013;36(5):1422–8.PubMedPubMedCentralCrossRef
24.
go back to reference Jager S, Wahl S, Kroger J, Sharma S, Hoffmann P, Floegel A, et al. Genetic variants including markers from the exome chip and metabolite traits of type 2 diabetes. Sci Rep. 2017;7(1):6037.PubMedPubMedCentralCrossRef Jager S, Wahl S, Kroger J, Sharma S, Hoffmann P, Floegel A, et al. Genetic variants including markers from the exome chip and metabolite traits of type 2 diabetes. Sci Rep. 2017;7(1):6037.PubMedPubMedCentralCrossRef
25.
go back to reference Wang F, Wang J, Li Y, Yuan J, Yao P, Wei S, et al. Gallstone disease and type 2 diabetes risk: a Mendelian randomization study. Hepatology. 2018. Wang F, Wang J, Li Y, Yuan J, Yao P, Wei S, et al. Gallstone disease and type 2 diabetes risk: a Mendelian randomization study. Hepatology. 2018.
26.
go back to reference Qi L, Hu FB, Hu G. Genes, environment, and interactions in prevention of type 2 diabetes: a focus on physical activity and lifestyle changes. Curr Mol Med. 2008;8(6):519–32.PubMedCrossRef Qi L, Hu FB, Hu G. Genes, environment, and interactions in prevention of type 2 diabetes: a focus on physical activity and lifestyle changes. Curr Mol Med. 2008;8(6):519–32.PubMedCrossRef
27.
go back to reference Bos MM, Smit RAJ, Trompet S, van Heemst D, Noordam R. Thyroid signaling, insulin resistance, and 2 diabetes mellitus: a Mendelian randomization study. J Clin Endocrinol Metab. 2017;102(6):1960–70.PubMedCrossRef Bos MM, Smit RAJ, Trompet S, van Heemst D, Noordam R. Thyroid signaling, insulin resistance, and 2 diabetes mellitus: a Mendelian randomization study. J Clin Endocrinol Metab. 2017;102(6):1960–70.PubMedCrossRef
28.
go back to reference Liu J, van Klinken JB, Semiz S, van Dijk KW, Verhoeven A, Hankemeier T, et al. A Mendelian randomization study of metabolite profiles, fasting glucose, and type 2 diabetes. Diabetes. 2017;66(11):2915–26.PubMedCrossRef Liu J, van Klinken JB, Semiz S, van Dijk KW, Verhoeven A, Hankemeier T, et al. A Mendelian randomization study of metabolite profiles, fasting glucose, and type 2 diabetes. Diabetes. 2017;66(11):2915–26.PubMedCrossRef
29.
go back to reference Schmidt AF, Swerdlow DI, Holmes MV, Patel RS, Fairhurst-Hunter Z, Lyall DM, et al. PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2017;5(2):97–105.PubMedPubMedCentralCrossRef Schmidt AF, Swerdlow DI, Holmes MV, Patel RS, Fairhurst-Hunter Z, Lyall DM, et al. PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2017;5(2):97–105.PubMedPubMedCentralCrossRef
30.
go back to reference MacArthur J, Bowler E, Cerezo M, Gil L, Hall P, Hastings E, et al. The new NHGRI-EBI catalog of published genome-wide association studies (GWAS catalog). Nucleic Acids Res. 2017;45(D1):D896–901.PubMedCrossRef MacArthur J, Bowler E, Cerezo M, Gil L, Hall P, Hastings E, et al. The new NHGRI-EBI catalog of published genome-wide association studies (GWAS catalog). Nucleic Acids Res. 2017;45(D1):D896–901.PubMedCrossRef
31.
go back to reference Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.PubMedPubMedCentralCrossRef Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.PubMedPubMedCentralCrossRef
32.
go back to reference Collaborators GBDRF. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1345–422.CrossRef Collaborators GBDRF. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1345–422.CrossRef
34.
go back to reference Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–504.PubMedPubMedCentralCrossRef Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–504.PubMedPubMedCentralCrossRef
35.
go back to reference Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365(9467):1333–46.PubMedCrossRef Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005;365(9467):1333–46.PubMedCrossRef
36.
go back to reference Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278–316.PubMedPubMedCentralCrossRef Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278–316.PubMedPubMedCentralCrossRef
37.
go back to reference Xue A, Wu Y, Zhu Z, Zhang F, Kemper KE, Zheng Z, et al. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun. 2018;9(1):2941.PubMedPubMedCentralCrossRef Xue A, Wu Y, Zhu Z, Zhang F, Kemper KE, Zheng Z, et al. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun. 2018;9(1):2941.PubMedPubMedCentralCrossRef
38.
go back to reference Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129–40.PubMedCrossRef Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129–40.PubMedCrossRef
39.
go back to reference Shan Z, Ma H, Xie M, Yan P, Guo Y, Bao W, et al. Sleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2015;38(3):529–37.PubMedCrossRef Shan Z, Ma H, Xie M, Yan P, Guo Y, Bao W, et al. Sleep duration and risk of type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2015;38(3):529–37.PubMedCrossRef
40.
go back to reference McBain H, Mulligan K, Haddad M, Flood C, Jones J, Simpson A. Self management interventions for type 2 diabetes in adult people with severe mental illness. Cochrane Database Syst Rev. 2016;4:CD011361.PubMed McBain H, Mulligan K, Haddad M, Flood C, Jones J, Simpson A. Self management interventions for type 2 diabetes in adult people with severe mental illness. Cochrane Database Syst Rev. 2016;4:CD011361.PubMed
41.
go back to reference The Lancet Diabetes E. Poor mental health in diabetes: still a neglected comorbidity. Lancet Diabetes Endocrinol. 2015;3(6):393. The Lancet Diabetes E. Poor mental health in diabetes: still a neglected comorbidity. Lancet Diabetes Endocrinol. 2015;3(6):393.
42.
go back to reference Huang MH, Chen MH, Huang KL, Hsu JW, Bai YM, Cheng CM, et al. Increased risk of type 2 diabetes among the siblings of patients with schizophrenia. CNS Spectr. 2019;24(4):453–9.PubMedCrossRef Huang MH, Chen MH, Huang KL, Hsu JW, Bai YM, Cheng CM, et al. Increased risk of type 2 diabetes among the siblings of patients with schizophrenia. CNS Spectr. 2019;24(4):453–9.PubMedCrossRef
43.
go back to reference Vancampfort D, Correll CU, Galling B, Probst M, De Hert M, Ward PB, et al. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis. World Psychiatry. 2016;15(2):166–74.PubMedPubMedCentralCrossRef Vancampfort D, Correll CU, Galling B, Probst M, De Hert M, Ward PB, et al. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis. World Psychiatry. 2016;15(2):166–74.PubMedPubMedCentralCrossRef
44.
go back to reference Holt RI, Mitchell AJ. Diabetes mellitus and severe mental illness: mechanisms and clinical implications. Nat Rev Endocrinol. 2015;11(2):79–89.PubMedCrossRef Holt RI, Mitchell AJ. Diabetes mellitus and severe mental illness: mechanisms and clinical implications. Nat Rev Endocrinol. 2015;11(2):79–89.PubMedCrossRef
45.
go back to reference Moulton CD, Pickup JC, Ismail K. The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol. 2015;3(6):461–71.PubMedCrossRef Moulton CD, Pickup JC, Ismail K. The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol. 2015;3(6):461–71.PubMedCrossRef
46.
go back to reference Arredondo A. Diabetes duration, HbA1c, and cause-specific mortality in Mexico. Lancet Diabetes Endocrinol. 2018;6(6):429–31.PubMedCrossRef Arredondo A. Diabetes duration, HbA1c, and cause-specific mortality in Mexico. Lancet Diabetes Endocrinol. 2018;6(6):429–31.PubMedCrossRef
47.
go back to reference Sathish T. Diabetes prevention and lifestyle intervention in resource-limited settings. Lancet Diabetes Endocrinol. 2019;7(3):165–7.PubMedCrossRef Sathish T. Diabetes prevention and lifestyle intervention in resource-limited settings. Lancet Diabetes Endocrinol. 2019;7(3):165–7.PubMedCrossRef
48.
go back to reference Newman JD, Vani AK, Aleman JO, Weintraub HS, Berger JS, Schwartzbard AZ. The changing landscape of diabetes therapy for cardiovascular risk reduction: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72(15):1856–69.PubMedPubMedCentralCrossRef Newman JD, Vani AK, Aleman JO, Weintraub HS, Berger JS, Schwartzbard AZ. The changing landscape of diabetes therapy for cardiovascular risk reduction: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72(15):1856–69.PubMedPubMedCentralCrossRef
49.
go back to reference Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.PubMedCrossRef Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.PubMedCrossRef
50.
go back to reference Junttila MJ, Kiviniemi AM, Lepojarvi ES, Tulppo M, Piira OP, Kentta T, et al. Type 2 diabetes and coronary artery disease: preserved ejection fraction and sudden cardiac death. Heart Rhythm. 2018;15(10):1450–6.PubMedCrossRef Junttila MJ, Kiviniemi AM, Lepojarvi ES, Tulppo M, Piira OP, Kentta T, et al. Type 2 diabetes and coronary artery disease: preserved ejection fraction and sudden cardiac death. Heart Rhythm. 2018;15(10):1450–6.PubMedCrossRef
51.
Metadata
Title
A network analysis framework of genetic and nongenetic risks for type 2 diabetes
Authors
Yuan Zhang
Shu Li
Zhi Cao
Yangyang Cheng
Chenjie Xu
Hongxi Yang
Li Sun
Hongxiao Jiao
Ju Wang
Wei-Dong Li
Yaogang Wang
Publication date
01-06-2021
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 2/2021
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-020-09585-2

Other articles of this Issue 2/2021

Reviews in Endocrine and Metabolic Disorders 2/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.